STOCK TITAN

[Form 4] CAMDEN NATIONAL CORP Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Camden National Corporation director Maxwell Raina acquired 357 shares of Camden National Corp common stock on 09/19/2025 at a price of $40.22 per share under the company’s 2022 Equity and Incentive Plan in lieu of director fees. Following the transaction, Raina beneficially owns 2,136.359 shares, a total that includes 19.758 shares added via the company’s dividend reinvestment program since the last filing. The Form 4 was filed individually and signed by a POA on 09/23/2025. The filing discloses a routine equity grant and dividend reinvestment activity by a director.

Il direttore Maxwell Raina di Camden National Corporation ha acquisito 357 azioni di Camden National Corp in azioni ordinarie il 19/09/2025 al prezzo di $40.22 per azione, ai sensi del piano azioni e incentivi del 2022, in lieu of director fees. Dopo l’operazione, Raina detiene beneficiamente 2.136.359 azioni, una cifra che include 19.758 azioni aggiunte tramite il piano di reinvestimento dei dividendi dall’ultimo deposito. Il modulo Form 4 è stato presentato individualmente e firmato da un procuratore il 23/09/2025. La presentazione riferisce di una normale assegnazione azionaria e di attività di reinvestimento dei dividendi da parte di un consigliere.
El director Maxwell Raina de Camden National Corporation adquirió 357 acciones de Camden National Corp en acciones comunes el 19/09/2025 a un precio de $40.22 por acción, conforme al plan de acciones e incentivos de 2022 de la empresa, en lugar de honorarios de director. Tras la operación, Raina posee de forma beneficiosa 2,136.359 acciones, un total que incluye 19.758 acciones añadidas a través del programa de reinversión de dividendos desde la última presentación. El Formulario 4 fue presentado de manera individual y firmado por un poder autorizado el 23/09/2025. La presentación divulga una asignación de acciones rutinaria y una actividad de reinversión de dividendos por parte de un director.
Camden National Corporation 이사 Maxwell Raina는 Camden National Corp 보통주를 357주 2025-09-19에 주당 $40.22의 가격으로 매입했으며, 이는 회사의 2022년 주식 및 인센티브 계획에 따른 것으로 이사 수수료 대신 이뤄진 거래입니다. 거래 후 Raina는 이익 소유 2,136.359주를 보유하게 되었으며, 이는 마지막 공시 이후 회사의 배당 재투자 프로그램을 통해 추가된 19.758주를 포함합니다. Form 4는 개인적으로 제출되었고 2025-09-23에 위임장을 가진 사람이 서명했습니다. 이 공시는 이사에 의한 일상적인 주식 부여 및 배당 재투자 활동을 공개합니다.
Le directeur Maxwell Raina de Camden National Corporation a acquis 357 actions ordinaires de Camden National Corp le 19/09/2025 au prix de $40.22 par action, dans le cadre du plan d’actions et d’incitations de 2022 de l’entreprise, en remplacement des honoraires de directeur. Après la transaction, Raina détient bénéficiairement 2 136,359 actions, un total qui inclut 19 758 actions ajoutées via le programme de réinvestissement des dividendes depuis la dernière divulgation. Le Formulaire 4 a été déposé individuellement et signé par une procuration le 23/09/2025. Le dépôt révèle une attribution d’actions routinière et une activité de réinvestissement des dividendes par un administrateur.
Der Camden National Corporation-Direktor Maxwell Raina erwarb 357 Aktien der Camden National Corp Stammaktien am 19.09.2025 zu einem Preis von $40.22 pro Aktie im Rahmen des Unternehmensplans 2022 für Aktien und Anreize, statt Direktorengebühren. Nach der Transaktion besitzt Raina vorteilhaft 2.136,359 Aktien, eine Summe, die 19.758 Aktien umfasst, die seit der letzten Einreichung über das Dividenden-Reinvestitionsprogramm des Unternehmens hinzugefügt wurden. Das Form 4 wurde einzeln eingereicht und am 23.09.2025 von einer POA unterschrieben. Die Einreichung gibt eine routinemäßige Aktienzuteilung und Dividenden-Reinvestitionsaktivität eines Direktors an.
قام المدير Maxwell Raina في Camden National Corporation بالاستحواذ على 357 سهماً من أسهم Camden National Corp العادية في 19/09/2025 بسعر $40.22 للسهم، بموجب خطة الأسهم والحوافز الخاصة بالشركة لعام 2022، بدلاً من أتعاب المدراء. بعد الصفقة، يمتلك Raina بشكل مستفيد 2,136.359 سهماً، وهو إجمالي يشمل 19.758 سهماً أضيفت عبر برنامج إعادة استثمار الأرباح منذ آخر إقرار. تم تقديم نموذج Form 4 بشكل فردي وتوقيع بموجب توكيل في 23/09/2025. يبيّن الإقرار تخصيصاً تقليدياً للأسهم ونشاطاً لإعادة استثمار الأرباح من قبل مدير.
Camden National Corporation 董事 Maxwell Raina 于 2025-09-19 以每股 $40.22 的价格,依据公司 2022 年股权与激励计划,购买了 357 股 Camden National Corp 普通股,以代替董事费用。交易后,Raina 受益持有 2,136.359 股,其中包括自上次申报以来通过公司股息再投资计划新增的 19.758 股。Form 4 以个人名义提交,并由 POA 于 2025-09-23 署名。该申报揭示了董事的例行股票授予和股息再投资活动。
Positive
  • Equity-based compensation used to align director incentives, as 357 shares were acquired under the 2022 Equity and Incentive Plan
  • Dividend reinvestment participation added 19.758 shares since the last filing, showing continued director participation in company programs
Negative
  • None.

Insights

TL;DR: Director received equity in lieu of fees, modestly increasing ownership; typical governance practice with no adverse signals.

The reported acquisition of 357 shares under the 2022 Equity and Incentive Plan reflects a standard compensation mechanism for non-employee directors who elect equity rather than cash. Including 19.758 shares from dividend reinvestment, the total beneficial ownership of 2,136.359 shares remains modest relative to institutional holdings. The filing was made individually and executed by a POA, which is common for administrative processing. There are no indications of unusual timing or related-party transactions in the disclosure provided.

TL;DR: Small, non-material share acquisition at $40.22 per share; impact on ownership and valuation is immaterial.

The acquisition price of $40.22 for 357 shares is documented and the transaction code indicates an award under the equity plan. The incremental increase of 19.758 shares from DRIP is explicitly noted. From an investor-impact perspective, the transaction size and resulting beneficial ownership do not appear material to company capitalization or control. The disclosure meets Section 16 reporting requirements and provides clear mechanics for the change in holdings.

Il direttore Maxwell Raina di Camden National Corporation ha acquisito 357 azioni di Camden National Corp in azioni ordinarie il 19/09/2025 al prezzo di $40.22 per azione, ai sensi del piano azioni e incentivi del 2022, in lieu of director fees. Dopo l’operazione, Raina detiene beneficiamente 2.136.359 azioni, una cifra che include 19.758 azioni aggiunte tramite il piano di reinvestimento dei dividendi dall’ultimo deposito. Il modulo Form 4 è stato presentato individualmente e firmato da un procuratore il 23/09/2025. La presentazione riferisce di una normale assegnazione azionaria e di attività di reinvestimento dei dividendi da parte di un consigliere.
El director Maxwell Raina de Camden National Corporation adquirió 357 acciones de Camden National Corp en acciones comunes el 19/09/2025 a un precio de $40.22 por acción, conforme al plan de acciones e incentivos de 2022 de la empresa, en lugar de honorarios de director. Tras la operación, Raina posee de forma beneficiosa 2,136.359 acciones, un total que incluye 19.758 acciones añadidas a través del programa de reinversión de dividendos desde la última presentación. El Formulario 4 fue presentado de manera individual y firmado por un poder autorizado el 23/09/2025. La presentación divulga una asignación de acciones rutinaria y una actividad de reinversión de dividendos por parte de un director.
Camden National Corporation 이사 Maxwell Raina는 Camden National Corp 보통주를 357주 2025-09-19에 주당 $40.22의 가격으로 매입했으며, 이는 회사의 2022년 주식 및 인센티브 계획에 따른 것으로 이사 수수료 대신 이뤄진 거래입니다. 거래 후 Raina는 이익 소유 2,136.359주를 보유하게 되었으며, 이는 마지막 공시 이후 회사의 배당 재투자 프로그램을 통해 추가된 19.758주를 포함합니다. Form 4는 개인적으로 제출되었고 2025-09-23에 위임장을 가진 사람이 서명했습니다. 이 공시는 이사에 의한 일상적인 주식 부여 및 배당 재투자 활동을 공개합니다.
Le directeur Maxwell Raina de Camden National Corporation a acquis 357 actions ordinaires de Camden National Corp le 19/09/2025 au prix de $40.22 par action, dans le cadre du plan d’actions et d’incitations de 2022 de l’entreprise, en remplacement des honoraires de directeur. Après la transaction, Raina détient bénéficiairement 2 136,359 actions, un total qui inclut 19 758 actions ajoutées via le programme de réinvestissement des dividendes depuis la dernière divulgation. Le Formulaire 4 a été déposé individuellement et signé par une procuration le 23/09/2025. Le dépôt révèle une attribution d’actions routinière et une activité de réinvestissement des dividendes par un administrateur.
Der Camden National Corporation-Direktor Maxwell Raina erwarb 357 Aktien der Camden National Corp Stammaktien am 19.09.2025 zu einem Preis von $40.22 pro Aktie im Rahmen des Unternehmensplans 2022 für Aktien und Anreize, statt Direktorengebühren. Nach der Transaktion besitzt Raina vorteilhaft 2.136,359 Aktien, eine Summe, die 19.758 Aktien umfasst, die seit der letzten Einreichung über das Dividenden-Reinvestitionsprogramm des Unternehmens hinzugefügt wurden. Das Form 4 wurde einzeln eingereicht und am 23.09.2025 von einer POA unterschrieben. Die Einreichung gibt eine routinemäßige Aktienzuteilung und Dividenden-Reinvestitionsaktivität eines Direktors an.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Maxwell Raina

(Last) (First) (Middle)
2 ELM STREET
P.O. BOX 310

(Street)
CAMDEN ME 04843

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/19/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/19/2025 A 357(1) A $40.22 2,136.359(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.
2. Includes 19.758 shares acquired since the last filing as a result of participation in the Company's dividend reinvestment program.
Remarks:
Christopher G. Hutchinson, POA 09/23/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Maxwell Raina report on Form 4 for CAC?

The Form 4 reports the acquisition of 357 shares of Camden National Corp common stock on 09/19/2025 at $40.22 per share.

How many shares does Maxwell Raina beneficially own after the reported transaction?

Following the reported transaction, Maxwell Raina beneficially owns 2,136.359 shares.

Were the shares acquired as part of a compensation plan or purchased on the open market?

The shares were acquired under Camden National Corporation’s 2022 Equity and Incentive Plan in lieu of director fees.

Does the filing show participation in a dividend reinvestment program for CAC?

Yes. The filing notes 19.758 shares were acquired since the last filing via the company’s dividend reinvestment program.

When was the Form 4 filed and who signed it?

The Form 4 was executed by a power of attorney, Christopher G. Hutchinson, POA, on 09/23/2025.
Camden Natl Corp

NASDAQ:CAC

CAC Rankings

CAC Latest News

CAC Latest SEC Filings

CAC Stock Data

659.38M
16.58M
1.78%
73.89%
2.76%
Banks - Regional
National Commercial Banks
Link
United States
CAMDEN